Skip to content

HELP

Cybin, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$12.37
−11.77%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 12, 2026
EPS estimate
-$0.67
Revenue estimate

Latest reported

Last report date
Aug 14, 2026
EPS actual
-$0.91
EPS estimate
-$0.84
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
2
EPS misses (12Q)
6
EPS in line (12Q)
0
Avg surprise (4Q)
-31.2%
Revenue beats (12Q)
0

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$45
PT range
$16 – $70
Analysts
5
5 Buy0 Hold0 Sell
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 14, 2026-$0.84-$0.91Miss -8.84%
Jun 30, 2026-$1.04-$0.96Beat 7.81%$1.3M
Feb 13, 2026-$0.53-$0.72Miss -35.85%
Nov 13, 2025-$0.74-$1.39Miss -87.84%
Aug 13, 2025-$0.96-$1.10Miss -14.72%
Jun 30, 2025-$0.85-$1.44Miss -68.76%
Nov 13, 2024-$0.98-$2.86Miss -190.85%
Aug 8, 2024-$0.97-$0.12Beat 88.02%
Mar 31, 2024-$0.17
Nov 14, 2023-$0.05
Aug 14, 2023-$0.06
Mar 31, 2023-$0.07

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026